Outlook Therapeutics Revenue, Growth & Competitor Profile

DBA ONCOBIOLOGICS INC

Company Profile & Annual Report for Outlook Therapeutics

Access the complete profile.

Outlook Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 325414 Biological Product Manufacturing
Address	485 Route 1 South Building F, Suite 320 Iselin, NJ 08830

Note: Revenues for privately held companies are statistical evaluations.


Outlook Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Outlook Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Outlook Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Outlook Therapeutics Annual Revenue and Growth Rate

Outlook Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Outlook Therapeutics's revenues are gauged from an analysis of company filings.

Outlook Therapeutics's Income Statement (based on Industry Averages)

Outlook Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Outlook Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
April 16, 2024	1	38%	$13 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Outlook Therapeutics is developing and marketing. Outlook Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LYTENAVA Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease	09/14/2023
LYTENAVA NAVIGATOR Printed publications in the nature of brochures, pamphlets, and newsletters in the field of medical information and patient support	03/09/2023

See all trademarks and details in the Full Report.

Market Share of Outlook Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Outlook Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Outlook Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SANOFI-AVENTIS PUERTO RICO	Bridgewater, NJ	100
AMNEAL PHARMACEUTICALS OF NEW YORK	Bridgewater, NJ	17
TRIS PHARMA	Monmouth Junction, NJ	3
BAUSCH HEALTH US	Bridgewater, NJ	3
LEGEND BIOTECH USA	Somerset, NJ	3
BRACCO DIAGNOSTICS	Monroe Township, NJ	2

Future Competition: Outlook Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Outlook Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)